lymphoid microenvironments and innate lymphoid cells in the gut
TRANSCRIPT
Review
Structure and function of lymphoid tissues
Lymphoid microenvironments andinnate lymphoid cells in the gutClaire Pearson, Holm H. Uhlig and Fiona Powrie
Translational Gastroenterology Unit, Nuffield Department of Clinical Medicine, John Radcliffe Hospital,
University of Oxford, Oxford OX3 9DU, UK
Gut-associated lymphoid tissue (GALT) is a sensor re-gion for luminal content and plays an important role inlymphoid maturation, activation and differentiation. Itcomprises isolated and aggregated lymphoid follicles,cryptopatches (CPs) and tertiary lymphoid tissue. Innatelymphoid cells (ILCs) play a central role within GALT.Prenatal GALT development is dependent on ILC lym-phoid-inducer function. Postnatally, these cells rapidlyrespond to commensal and pathogenic intestinal bacte-ria, parasites and food components by polarized cyto-kine production [such as interleukin (IL)-22, IL-17 or IL-13]and further contribute to GALT formation and function.Here, we discuss how ILCs shape lymphoid intestinalmicroenvironments and act as amplifier cells for innateand adaptive immune responses.
Innate lymphoid cells (ILCs) as regulators of the gutmicroenvironmentCoexistence of vertebrates with selected commensal intes-tinal microbiota is not only part of a metabolic strategy toextract nutrients from food, but also acts as a defencemechanism. Interactions between epithelial cells, stromalcells, and innate and adaptive haematopoietic immunecells form the basis for a beneficial mutualistic relationwith commensal microbiota, and also for effective defencestrategies towards pathogens [1,2]. To promote appropri-ate immune responses in the gut, complex networks ofspecialised cells have evolved that act within the laminapropria and gut associated lymphoid tissue (GALT). With-in the GALT, cryptopatches (CP), isolated lymphoid folli-cles (ILFs), aggregated lymphoid follicles [such as Peyer’spatches (PPs)] and ILF-like tertiary lymphoid tissue (TLT)can be distinguished based on differences in cellular com-position, genetically predetermined developmental factors,as well as dependence on environmental triggers andresponse during tissue inflammation [3].
ILCs are an evolutionarily conserved and developmen-tally related family ofhaematopoietic cells that contribute tohost defence and immune homeostasis. Classical membersof the ILC family are natural killer (NK) cells and lymphoidtissue inducer (LTi) cells. However in the past three years,related but functionally distinct ILC populations have beendiscovered, engendering intense interest in their lineage
Corresponding author: Powrie, F. ([email protected]).Keywords: gut-associated lymphoid tissue; innate lymphoid cell; lymphoid inducercell
1471-4906/$ – see front matter � 2012 Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.it.2
relationship and contribution to intestinal physiology andpathophysiology [4]. One of themost striking findings is thefunctional similarity between ILC subpopulations andadaptive CD4+ T helper cell subsets. ILC subsets are con-trolled by transcription factor modules and promptly pro-duce downstream effector cytokines such as IFN-g, IL-17,IL-22 and IL-13 that are homologous to defined Th subsets[4–7]. Based on these results, it is tempting to speculate thatcytokine-driven immune effector modules present in ILCsrepresent a primitive form of host defence subsequentlyacquired by the adaptive immune system.
To date, four distinct new ILC populations, termed LTi-like, NK22, CD4– NKp46– and nuocyte/natural helpercells, have been described and their properties are sum-marised in Box 1.
Alongside the established role of ILCs in GALT devel-opment, it is now evident that ILCs have additional func-tions throughout life beyond that of prenatal lymphoidtissue organisation. Here, we review the developmentallyprogrammed and environmentally driven functions of ILCpopulations; particularly their cytokine production andresponsiveness, which shape the gut microenvironmentand contribute to host protection and tissue inflammation.
LTi cells in the development of GALTLTi cells were originally identified in lymph nodes [8], andtheir function in the formation of lymphoid tissues, includ-ing GALT, is well described [9]. Classical LTi cells arefound prenatally and shortly after birth. A low frequency ofcells with a similar phenotype is also present in adults.However, it is not known whether these represent persis-tence of foetal populations or a developmentally distinctLTi-like population. Both foetal LTi and adult LTi-likecells express interleukin 7 receptor (IL-7R) a, and lympho-toxin (LT) as well as the transcription factor RAR-relatedorphan receptor (ROR)gt [10,11]. There are two RORg
isoforms, RORg and RORgt. The latter is shorter andexpression is restricted primarily to the thymus, Th17 cellsand certain ILC populations, including LTi cells. However,the two isoforms are very closely related, and it has notalways been possible to distinguish the relative contribu-tions of each isoform because cells expressing RORgt usu-ally also express RORg [12]. RORgt is absolutely requiredfor LTi development [10] and signalling via IL7–IL-7Ra
leads to RORgt as well as LT expression [13]. LT surfaceexpression on LTi cells signals to organiser stromal cells
012.04.004 Trends in Immunology, June 2012, Vol. 33, No. 6 289
Box 1. ILC populations found within the gut
All gut ILC populations share a common requirement for the
transcriptional regulator inhibitor of DNA binding 2 (Id2). LTi, LTi-
like, NK22 and CD4–NKp46– cells also depend on expression of
RORgt. All ILCs are negative for lymphoid lineage markers B220,
CD11b, CD3 or T cell receptor (TCR)b, but do express Thy1 and the
IL-7 receptor.
LTi and LTi-like cells
Definition: LTi cells are present in the embryo and organise
lymphoid tissue during foetal development [8]. Recently, cells with a
similar phenotype have been described in adult individuals [55].
Whether these LTi-like cells still mediate lymphoid inducer function
is unclear.
Location: All lymphoid structures including PPs, CPs and ILFs
throughout the intestinal tract.
Phenotype: LTi/LTi-like cells express IL-7 receptor a, LT a and b,
cKit, CCR6, CCR7 and chemokine CXC receptor (CXCR)5 [4]. In mice,
classical LTi cells coexpress CD4 and cKit. However a murine
population of CD4– LTis has been described and human LTis do not
express CD4 [55]. LTi-like cells primarily secrete IL-17 and IL-22
[5,55].
NK22 cells
Definition: NK22 cells express NK surface markers but lack
perforin and granzyme, and do not induce cell lysis. Human NK22
cells are IL-7-dependent and IL-15-independent [54].
Location: Small intestine and colon but have also been found in
the tonsils [6,54].
Phenotype: NK22 cells express NKp46 in mice, and NKp44 in
humans, and secrete IL-22 [6,18,53].
CD4– NKp46– cells
Definition: A phenotypically distinct ILC population that has a
pathogenic role in mouse models of colitis [39,50].
Location: Predominantly found in the colon and the caecum, and
less frequently in the small intestine [39,50].
Phenotype: This population lacks the expression of CD4, NKp46
and cKit, but expresses Stem cell antigen (Sca)-1 [39,50]. CD4–
NKp46– cells are IL-23-responsive and have been shown to secrete a
spectrum of cytokines such as IL-17A, IFNg and IL-22 [50].
Natural helper cells/nuocytes
Definition: Natural helper cells/nuocytes are IL-25- and IL-33-
responsive ILCs [61,62]. They are RORgt-independent but require
RORa and NOTCH signalling for their development. They do not
have in vitro LTi activity [62,63].
Location: Natural helper cells are found in FALCs in human and
mouse mesentery [62]. Nuocytes were described in mLNs and lungs
[61].
Phenotype: Natural helper cells and nuocytes express the IL-33R
and IL-25 receptor component IL-17RB. Murine cells are cKit+ and
Sca-1+ but RORgt–. Human IL-25- and IL-33-responsive ILCs express
the surface markers CD161 and CRTH2 and express no or low levels
of RORg [66]. After stimulation with IL-33 and IL-25, these cells
secrete IL-4, IL-5 and IL-13.
Review Trends in Immunology June 2012, Vol. 33, No. 6
that express LTbR leading to expression of adhesion mole-cules such as intercellular cell adhesionmolecule (ICAM)1,and subsequent secretion of chemokines involved in therecruitment of haematopoietic cells, particularly B and Tcells [13]. Thus, through a series of complex signallingevents, LTi cells play a pivotal role in orchestration oforganised lymphoid tissue development [14].
CPs
CPs (reviewed in [15]) are found after birth throughout thesmall intestine and colon. CPs contain dendritic cells(DCs), common lymphoid progenitor (Lin– cKit+ IL-7Ra+)cells, LTi-like cells [16] and a few NKp46+ NK22 cells[17,18] (Figure 1). In a mouse model lacking NK22 cellsand most LTi/LTi-like cells due to an absence of thetranscription factor aryl hydrocarbon receptor (Ahr), CPs
290
were notably absent [19]. A more severe loss of ILCs occursin the absence of RORgt, resulting in the complete absenceof all forms of GALT [20]. CPs are present in recombinationactivating gene (Rag)-deficient hosts that lack T and Bcells, as well as in germ-free animals, demonstrating theevolutionarily ancient and genetically determined innatefunction of LTi/LTi-like cells.
Although CPs have been described in mice [21], theyhave not been found in humans. However, it was recentlyproposed that clusters of chemokine CC receptor (CCR)6-positive cells detected in the human intestine identify LTicells and CP-like aggregates [22]. The functional relevanceof CPs is a source of debate due to conflicting data onwhether they promote thymic-independent generation ofintraepithelialab and gdT cells [15,23,24], or whether theyare simply part of dynamic and interconvertible GALTstructures with other functions [25].
ILFs
ILFs have been described in both the small intestine andcolonofhumansandmice [26,27]. ILFsare composedmainlyof B cells surrounded by LTi/LTi-like cells, DCs and stromalcells [28,29]. B cells within ILFs preferentially differentiateinto IgA+ plasma cells facilitating local intestinal immunity[30]. ILFs may develop from CPs in a nucleotide oligomer-isation domain (NOD)-dependent manner through interac-tions with microbiota [21,31,32]. As NODs recognisepeptidoglycans from bacterial components, this provides afunctional link between commensal bacteria and the devel-opment of ILFs. Indeed, administration of antibiotics canreverse ILF formation [33], reinforcing the concept thatmicrobial elements can reversibly modulate the develop-ment of structural components of the GALT. As with CPs,ILF formation is completely abrogated inmice lackingNK22cells andwith reduced numbers of LTi-like cells [19]. Recentstudies suggest that CPs and ILFsmay be linked. Colonisa-tion of germ-free animals with commensal bacteria leads toadjustment of the solitary lymphoid clusters, shifting fromCP-like clusters towards mature isolated lymphoid follicles[31].Basedon thesedata, it shouldbenoted that theabsenceof ILFs in mice lacking NK22 cells may be secondary to alack of CPs rather than a direct requirement for ILCs inmaturation of ILFs.
PPs and PP-like aggregated lymphoid follicles
PPs are organised aggregated lymphoid follicles primarilylocated in the ileum [34]. However, there are well docu-mented equivalent lymphoid structures located at thecaecal tip in mice or the appendix vermiformis in humans,and colonic patches have been described [35]. Similar tolymph node development, PP anlagen are formed in thefoetus and do not require the presence of intestinal micro-biota. However, maturation and germinal centre formationdoes not occur until after birth in humans [36]. This isconsistent with the requirement of the intestinal micro-biota for PP maturation in mice [37].
The PP/PP-like aggregated lymphoid tissues function inintestinal luminal content surveillance, allowing rapidmucosal amplification of B and T cell responses. The folli-cle-associated epithelium contains specialised microfold orM cells as well as intra- and transepithelial DCs (Figure 1).
[(Figure_1)TD$FIG]
Cryptopatch
Peyer’s patch
Isolated lymphoidfollicle
Mesenteric LN
B cell
Key:
T cellILC
Dendritic cell
Monocyte/macrophage
M cell
Epithelial cell
Steady state Inflammation
Tertiary lymphoidtissue
TRENDS in Immunology
Figure 1. Gut lymphoid microenvironment in health and disease. Lymphoid tissue of the small intestine and colon. CPs are small structures consisting mainly of ILCs and
DCs. These can mature into ILFs that contain B cell zones and germinal centres. PPs are aggregated lymphoid follicles with organised T and B cell areas. During
inflammation, tertiary lymphoid structures can also form that resemble ILFs. GALT-associated epithelium lacks goblet cells and has reduced mucus layer thickness. The
epithelial layer contains specialised ‘microfold’ (M) cells as well as intraepithelial and interdigitating transepithelial DCs. Both M cells as well as DCs can sample luminal
content and present it to tissue-resident GALT lymphocytes, or, in the case of DCs, possibly migrate the mLNs to present antigen there.
Review Trends in Immunology June 2012, Vol. 33, No. 6
Both cell types are probably involved in sampling of anti-gens from the intestinal lumen, and pass antigen to follic-ular and conventional DCs, as well as to lymphocytes suchas B cells [38]. This sampling and antigen presentationwithin the PP provides a rapid means of local adaptation ofthe immune system under steady state conditions.
Although PP formation depends on RORg expression,prenatal PPs form almost normally in Ahr-deficient ani-mals that lack NK22 cells and have reduced numbers ofLTi-like cells [19]. This suggests that PP formation is lessdependent on NK22 and more dependent on LTi cells. Thisis consistent with a current model that different ILCpopulations may induce PP versus CP and ILF formation,directly reflecting the predominance of different ILC popu-lations before and after birth [39].
ILCs in generation of TLTIntestinal inflammation leads not only to increased num-bers of scattered inflammatory cells within the epitheliumand lamina propria but also to development of TLT. Al-though larger in size, TLT resembles ILFs in structure[40].
Given the similarity of TLT to ILFs, a functional rolefor LTi cells in TLT formation seems likely. However, thesituation is more complex, because unlike immatureILFs, de novo TLT induction is not only dependent onLTbR-expressing stromal cells but also on LT-positive Bcells [32]. Furthermore, TLT can form in a microbiota-dependent manner in RORgt-deficient animals that lackILCs [40]. This indicates alternative pathways of organ-ogenesis mediated by LT-expressing activated B cells[40]. These results demonstrate that, in contrast to
genetically predetermined lymphoid structures, ILCsdo not play a nonredundant role in induced TLT forma-tion. However, in the absence of RORgt+ ILCs, de novoTLT formation is associated with exacerbated inflamma-tion suggesting differences in the functional TLT-drivenresponse [38].
Together, the data paint a complex picture in whichspecific ILC subpopulations contribute to formation ofGALT anlagen during different phases of pre- and postna-tal development. Through their lymphoid inducer function,ILC populations contribute to the remarkable adaptabilityof the intestinal immune response. Further understandingof the host, microbial and dietary factors that control thedifferential activity and timing of lymphoid inducer func-tion by different ILC populations may provide a basis formore rational manipulation of the intestinal immune re-sponse.
ILCs as immune effector cellsBeyond their role in lymphoid organogenesis, recent stud-ies have highlighted the role of ILCs as immune effectorcells. ILC populations all develop from a communal Id2-dependent precursor, and similar to T cells, further differ-entiate into cells secreting different cytokines, dependingon genetic and environmental factors [4]. Like T cells, thedevelopment and persistence of ILCs is dependent on IL-7,a pro-survival homeostatic cytokine. IL-7 may also modu-late proinflammatory cytokine secretion by ILCs [41]. Thedescribed diversity of ILC populations mirrors that ofdifferentiated subsets of CD4 T helper (Th) cells withevidence for Type-1-, Type-2- and Type-17-like ILC popu-lations. These overlapping functions of innate and
291
Review Trends in Immunology June 2012, Vol. 33, No. 6
adaptive lymphoid cells are driven by commonality incytokine-driven transcription factor expression that allowsthe cells to respond to the cytokine milieu and adapt theireffector functions accordingly. It is now appreciated that Tcell differentiation is more flexible than previouslythought, and that differentiated subsets can acquire al-tered functions by acquiring or shutting down transcrip-tion factor expression in response to environmental cues[42]. Whether such flexibility of function occurs amongdifferentiated ILC populations is not known. In this sectionwe dissect the role of ILCs as cytokine-secreting effectorcells in the mucosal immune response.
RORgt-dependent IL-17- and IL-22-secreting ILCsThe signal transducer and activator of transcription(STAT)-3-driven RORgt-dependent Type 17 response playsa pivotal role in mucosal host defence [43]. Althoughoriginally described as a property of Th17 cells, a similarmodule of cytokine production including IL-17A, IL-17Fand IL-22 is produced by mucosal unconventional T cellpopulations including gd T lymphocytes and mucosallyassociated invariant T cells, as well as ILC populations.IL-17A, IL-17F and IL-22 are key players in the Type 17response [44]. IL-17A and IL-17F induce chemokines thatpromote neutrophil accumulation, whereas IL-22 is impor-tant in bolstering intestinal epithelial barrier function [45].Through binding to its receptor on intestinal epithelialcells, IL-22 promotes mucin production and upregulationof antimicrobial peptides such as RegIIIb and RegIIIg thatmediate direct antimicrobial activity (reviewed in [46]).
A characteristic feature of Type 17 cells is their RORgt-driven expression of the IL-23R [47]. Although not requiredfor the differentiation of Th17 cells, IL-23 plays an impor-tant role in enhancing cytokine secretion by Th17 and otherType 17 lymphoid cells. Recent studies indicate that IL-23playsa crucial role indriving IL-22-mediatedhostprotectiveimmunity to the mouse intestinal pathogen Citrobacterrodentium [48]. By contrast, overzealous IL-23-driven Type17 responses towards intestinal bacteria canpromote chron-ic intestinal inflammation [49,50]. Recent studies suggestthat distinct RORgt-dependent ILC populations (pheno-types summarised in Box 1) contribute to IL-23-mediatedmucosal host defence and immune pathology.
LTi-like cells
Under homeostatic conditions, a significant proportion ofadult LTi-like cells in the intestine can secrete IL-22 [51].In amousemodel, CD4+ adult LTi cells were found to be anessential source of host protective IL-22 required for clear-ance of C. rodentium infection [51]. IL-22-producing LTi-like cells may therefore provide important early innatedefence towards intestinal bacterial pathogens before theadaptive T and B cell immune response [51].
NK22 cells
Although LTi-like cells can produce IL-17 and IL-22, NK22cells primarily secrete IL-22. Quantitatively, these cells arean important source of intestinal IL-22 and have also beenimplicated in host defence towards C. rodentium infection[52,53]. Currently, it is not known whether the NK22 ILCpopulation arises from single or multiple progenitors.
292
Lineage tracing experiments with cells isolated from thehuman tonsil (Lin– CD45int CD127hi) and mouse intestine(Lin– NKp46– RORgt+) have shown that adult LTi cells cangive rise to NK22 cells (CD56+ CD3– in humans, Lin–
NKp46+ RORgt+ in mice) [41,54,55]. However, it cannotbe excluded that the starting population in those experi-ments also contains ILC precursors, allowing both popula-tions to develop independently and in parallel. Indeed,another studywasunable to replicate the transition of adultLTi cells to NK22 cells using RORg/gt fate-mapping in vivoor following in vitro culture [39], favouring the idea thatthese are two separate populations.
Once differentiated, cytokines including IL-1b, stem cellfactor (SCF), IL-2 and IL-7, appear to play an important rolein controlling ILC function. For example, a combination ofIL-2 and IL-7 stimulates proliferation of human NK22 cellsin vitro. However culture with IL-7 alone induces IL-22secretion, whereas addition of IL-2, or IL-2 alone, altersthe cytokine profile in favour of interferon (IFN)g [56].
Recently it has been shown that IL-1 receptor and thedownstream adaptor myeloid differentiation primaryresponse gene (88) (MyD88) are required for basaland IL-23-induced IL-22 production by NKp46+ andNKp46– ILCs. ILC populations express high levels ofIL-1R and addition of IL-1b promotes IL-22 production[16]. These data highlight IL-1b, alongside IL-23, as a keyfactor in the intestinal innate IL-22 response.
CD4– NKp46– ILCs
Recently, a phenotypically distinct IL-7Ra+ Thy1+ CD4–
NKp46– ILC population that can induce tissue inflamma-tion in the gut has been described [50]. This IL-23-respon-sive and IL-17A, IFNg and IL-22-secreting inflammatorypopulation is present in the colon and preferentially accu-mulates during Helicobacter hepaticus-induced colitis inRag-deficientmice.Aphenotypically similarpopulationalsoaccumulates in an anti-CD40 model of innate colitis [50].Depletion of Thy1+ cells blocks the onset of colitis in bothmodels [50], indicating a functional role for these cells ininnate intestinal pathology. RORg/gt fate-mapping showedevolution of the ILC response in anti-CD40-induced colitis,with reductions in RORgt expression and IL-22 secretionand reciprocal increases in T-bet, a Th1-specific transcrip-tion factor, and IFNg production [41]. A similar functionalshift has been observed in the T cell transfermodel of colitisandmay reflect the adaptation of a pathogenic rather thanahost protective Type 17 response [49].
Studies in humans have validated those in the mousewith the identification of an IL-7Ra+ CD56– IL-23-respon-sive ILC population that resembles IL-7R a+ Thy1+ CD4–
NKp46– ILCs in mice. IL-7R a+ CD56– ILCs are selectivelyincreased in the ileumand/or colon of patients with Crohn’sdisease compared with control or ulcerative colitis patients[57]. Differential increases in IL-7Ra+ CD56– ILCs in CDare correlated with increased expression of IL17A andIL17F but not IL22 transcripts, suggesting these cellsare distinct from human NK22 cells but may constitutean additional source of proinflammatory IL-17. Althoughprovocative, these results are correlative and further stud-ies are required to prove a functional role of ILCs in humaninflammatory bowel disease (IBD) pathogenesis.
Review Trends in Immunology June 2012, Vol. 33, No. 6
RORgt and Ahr in ILC populations – role of the
microbiota and diet
Although initial studies showed that NK22 ILCs areabsent in germ-free mice [53], more recent studies havefound no role for the microbiota in ILC development,including NK22 cells [19,58]. Treatment of adult mice withbroad-spectrum antibiotics, however, does decrease thenumber of ILCs expressing RORgt in the small intestineand colon, suggesting either that the maintenance of ILCsis dependent on signalling from commensal microbiota, orthat the expression of RORgt itself is stabilised by micro-bial signals [41]. Relevant to this, it has been suggestedthat IL-7 acts to stabilise RORgt expression, promotingIL-22-expressing ILCs [41]. Whether the effects of themicrobiota are mediated through alterations in IL-7production remains to be determined.
The proportions of lamina propria RORgt+ ILCs varythroughout life. Before birth, the LTi population is mostabundant, but quickly after birth NK22 or CD4– NKp46–
cells dominate [39]. Analysis of precursor–product rela-tions has shown that culture of CD4+ LTi-like cells does notlead to development of different lineages of ILCs in vitro,suggesting that LTi cells are a fixed population [39]. Theseresults are consistent with the view that NK22 cells do notderive from LTi-like cells but rather from an alternativeprecursor.
Several recent papers have revealed a role for dietaryfactors, through Ahr activity, in modulating IL-22-produc-ing ILCs and induced lymphoid structures. Ahr is a basichelix–loop–helix transcription factor with natural andsynthetic ligands that is involved in responses to environ-mental triggers [59]. Ahr�/� mice lack CPs, ILFs andNKp46+ IL-22-producing cells in the small intestine andcolon. The dependence of LTi and LTi-like cells on Ahrremains unclear from the data [19,60]. Ahr maintainsIL22-producing cells and GALT development via Notch-dependent and-independent mechanisms [19]. Dietaryantigens from cruciferous vegetables, such as broccoli,contain Ahr ligands such as indole-3-carbinol (I3C) andare able to reconstitute CP and ILF formation in mice fed adiet from non-plant sources [60], although this was notconfirmed by another study [19]. These studies provide amolecular explanation for how dietary factors can directlymodulate intestinal ILC function and lymphoid structureformation.
RORgt-independent ILCs – nuocytes and natural helpercellsType 2 cytokine-secreting RORgt-independent ILCs, so-called nuocytes [61] and natural helper cells [62], havebeen identified within gut tissues and elsewhere [61,62],and appear to represent Th2-equivalent cells. Both of thesepopulations respond to IL-25 and IL-33, and induce expul-sion of the helminth Nippostrongylis brasiliensis in amouse model. Nuocytes produce IL-13 and are located inthe mesenteric lymph nodes (mLNs) [61]. Natural helpercells also respond to IL-25 by secretion of IL-13, IL-4 andIL-5, and are located in fat-associated lymphoid clusters(FALCs) within the peritoneum [62]. Unlike other ILCs,these populations are not dependent on RORgt, but doexpress IL-7Ra, confirming their lymphoid origin. A recent
study suggests that nuocytes also express (and are func-tionally dependent on) RORa for worm expulsion [63]. Aslightly different IL-25-responsive ILC population facili-tates worm expulsion in experimental Trichuris murisinfection. This latter population has multipotent progeni-tor capacity giving rise to monocytes/macrophages or baso-phils [64].
In the lung, depletion of natural helper cells using adepleting Thy1 antibody causes exaggerated pathology inresponse to influenza. These cells show selective expres-sion of wound repair genes, particularly amphiregulin,compared with splenic LTi-like cells [65]. Indeed, amphir-egulin is sufficient to restore tissue repair, and it will beinteresting to assess the role of such tissue repair path-ways in the gut in the context of IBD. Recently, human IL-25- and IL-33-responsive type 2 innate lymphoid cellsdefined by expression of CRTH2 and CD161 have beendetected in the human foetal gut (0.5–2.3% Lin�IL-7Ra+CRTH2+ cells among CD45+ cells, with low or nega-tive RORg expression) but are less frequent in adult ileum[66].
Interestingly after birth, as the gut is colonised withbacteria, the constitutive IL-22 production by ILCs (bothLTi-like and NK22) becomes reduced as microbiota-stim-ulated epithelial cells secrete IL-25 [58]. This raises theintriguing possibility that microbial-dependent IL-25production may induce IL-25-responsive Type 2 ILCs(Figure 2). Interactions between RORgt-dependent andindependent ILCs have not been well studied, and it ispossible that under conditions of high IL-25 concentra-tion there is functional plasticity allowing an IL-22-secreting RORgt+ ILC to become a RORgtlo/– ILC thatsecretes IL-5 and IL-13. It will be of interest to establishthe role of Type 2 ILCs in human inflammatorydiseases.
Direct cell–cell interactions between ILCs, B and T cellsIn addition to cytokine secretion, there is also evidence thatILCs can directly modify adaptive B and T cell responsesvia cell–cell interactions. Indeed RORgt+ ILCs coordinateT cell independent IgA class switching via follicular DCsand plasma cell differentiation via DCs in ILFs [29]. It hasbeen proposed that LTi cells were originally innate im-mune cells with the capacity to secrete proinflammatorycytokines and IL-22, and that these cells clustered togetherin CPs to promote epithelial integrity via secretion of IL-22[67]. Over time, this cluster of LTi cells may have acquiredadditional signalling pathways including LT signalling,which provides the ability to recruit B cells that can thenundergo T cell independent class switching. LTi-like cellsalso interact with CD4 memory cells through OX40L andCD30L expression [68,69]. A functional role for this directinteraction has been proposed based on the findings thatCD4 memory cells fail to persist when transferred intoRORg-deficient hosts that have no LTi cells. Whether thisis attributable to a lack of an LTi-mediated OX40 or CD30signal, or if it occurs indirectly due to the absence oforganised lymphoid structures in RORg�/� mice remainsto be established. Further examination of the interactionsof LTi-like cells or other ILC populations with adaptive Tand B cell populations will establish the functional
293
[(Figure_2)TD$FIG]
Key:
Epithelial cell
Fibroblast
Dendritic cell
B cell
Th1
Th2
Th17
Eosinophil
Mast cell
Neutrophil
IL-23
IL-17A / IL17FIL-22
RORγ
IL-7
IL-7R
LTβR
Lymphoid tissue inducer
IL-25
IL-23R
IL-13 / IL-5
IL-33
IL-15R
IL-2
IL-2R IL-25RIL-1RL1/IL-1RAP
NFkB/MAPK ?
kynurenine
AhR
LT
Environmental trigger(food, bacteria, worms)
Inflammatory trigger
ILC signal integrationand response pattern
Influence onmicroenvironment
ICAM
LTi / LTi-like
NK22
CD4-NKp46-
Natural helper
Helicobacter hepaticus Nippostrongylis brasiliensisTrichuris muris
Epithelialprotection
Type 17 dominantinflammation
Type 2 dominant inflammation
RegIIIβRegIIIγ
NOTCH RORα
ILC cell types
t-bet NOTCH
IL-15
Citrobacter rodentiumCruciferousvegetables dioxin
TRENDS in Immunology
Figure 2. Functional response modules of ILCs. ILC (e.g. LTi/ILC-like cells, NK22, CD4–NKp46–, natural helper/nuocytes) populations apply a set of partially shared response
modules towards different stimuli including pathogens, food or inflammatory triggers (cytokines). Each ILC population can respond with several response modules in
parallel. Basic response modules are lymphoid inducer function (green), IL22-driven epithelial protection (blue), Type-17-mediated inflammation (pink) or Type 2
inflammation (purple). Exogenous Ahr ligands within food or the environment (such as cruciferous vegetables or dioxin) as well as endogenous ligands (including
kynurenines) enable LTi and LTi-like cells to interact with LTbR+ stromal cells to form lymphoid structures, but can also stimulate IL-22 secretion. RORg-dependent ILCs are
stimulated by intestinal microbiota-driven IL-7, IL-15 or IL-23 signals. This can trigger an IL-22 response promoting epithelial integrity and antimicrobial peptide secretion.
RORg-dependent cells can mount antibacterial or antifungal IL-17 responses leading to neutrophil recruitment. Worm or parasite infection can activate an IL-25 or IL-33-
dependent Type 2 response, possibly through the nuclear factor kB pathway. This Type 2 response may influence T cells, eosinophils or mast cell responses. Arrows show
stimulation and lines show repression pathways.
Review Trends in Immunology June 2012, Vol. 33, No. 6
relevance of ILCs beyond lymphoid tissue formation inorganisms with an intact adaptive immune system.
Concluding remarksIn this review, we have highlighted the multiple activitiesof ILCs that influence the intestinal microenvironment,providing an explanation for how a relatively small num-ber of ILCs may play a substantial role in shaping theadaptive immune system. First, LTi cells function pre andpostnatally to generate organised lymphoid structures inthe gut. Second, ILCs establish rapid cytokine production
294
and can contribute to the polarisation of the subsequentadaptive immune response. Third, ILCs contribute to T cellindependent IgA production as well as the maintenance ofmemory T cells.
Despite rapid advances, several questions remain. ILClineage relations and plasticity are not fully understood.The functional role of ILCs in human intestinal lymphoidtissue generation, tissue remodelling, epithelial barrierfunction, and their pathogenic contribution to human in-testinal inflammatory diseases and the onset of cancer alsoneeds further clarification.
Review Trends in Immunology June 2012, Vol. 33, No. 6
AcknowledgementsF.P. and C.P. are funded by the Wellcome Trust.
References1 Artis, D. (2008) Epithelial-cell recognition of commensal bacteria and
maintenance of immune homeostasis in the gut.Nat. Rev. Immunol. 8,411–420
2 Hooper, L.V. and Macpherson, A.J. (2010) Immune adaptations thatmaintain homeostasis with the intestinal microbiota. Nat. Rev.Immunol. 10, 159–169
3 Cherrier, M. et al. (2012) Development and function of intestinal innatelymphoid cells. Curr. Opin. Immunol. http://dx.doi.org/10.1016/j.coi.2012.03.011
4 Spits, H. and Di Santo, J.P. (2011) The expanding family of innatelymphoid cells: regulators and effectors of immunity and tissueremodeling. Nat. Immunol. 12, 21–27
5 Takatori, H. et al. (2009) Lymphoid tissue inducer-like cells are aninnate source of IL-17 and IL-22. J. Exp. Med. 206, 35–41
6 Cella, M. et al. (2009) A human natural killer cell subset providesan innate source of IL-22 formucosal immunity.Nature 457, 722–725
7 Oliphant, C.J. et al. (2011) Insights into the initiation of type 2 immuneresponses. Immunology 134, 378–385
8 Mebius, R.E. et al. (1997) Developing lymph nodes collect CD4+CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicularcells but not T or B cells. Immunity 7, 493–504
9 van de Pavert, S.A. and Mebius, R.E. (2010) New insights into thedevelopment of lymphoid tissues. Nat. Rev. Immunol. 10, 664–674
10 Eberl, G. and Littman, D.R. (2003) The role of the nuclear hormonereceptor RORgammat in the development of lymph nodes and Peyer’spatches. Immunol. Rev. 195, 81–90
11 Cupedo, T. (2011) Human lymph node development: an inflammatoryinteraction. Immunol. Lett. 138, 4–6
12 Dzhagalov, I. et al. (2004) The roles of orphan nuclear receptors in thedevelopment and function of the immune system. Cell. Mol. Immunol.1, 401–407
13 Yoshida, H. et al. (1999) IL-7 receptor alpha+ CD3(–) cells in theembryonic intestine induces the organizing center of Peyer’spatches. Int. Immunol. 11, 643–655
14 Vondenhoff, M.F. et al. (2007) Lymphoid organogenesis in brief. Eur. J.Immunol. 37 (Suppl. 1), S46–S52
15 Eberl, G. and Sawa, S. (2010) Opening the crypt: current facts andhypotheses on the function of cryptopatches. Trends Immunol. 31, 50–55
16 Reynders, A. et al. (2011) Identity, regulation and in vivo function of gutNKp46+RORgammat+ and NKp46+RORgammat- lymphoid cells.EMBO J. 30, 2934–2947
17 Luci, C. et al. (2009) Influence of the transcription factor RORgammaton the development of NKp46+ cell populations in gut and skin. Nat.Immunol. 10, 75–82
18 Sanos, S.L. et al. (2009) RORgammat and commensal microflora arerequired for the differentiation of mucosal interleukin 22-producingNKp46+ cells. Nat. Immunol. 10, 83–91
19 Lee, J.S. et al. (2011) AHR drives the development of gut ILC22 cells andpostnatal lymphoid tissues via pathways dependent on and independentof Notch. Nat. Immunol. (http://dx.doi.org/10.1038/ni.2187)
20 Eberl, G. and Littman, D.R. (2004) Thymic origin of intestinalalphabeta T cells revealed by fate mapping of RORgammat+ cells.Science 305, 248–251
21 Bouskra, D. et al. (2008) Lymphoid tissue genesis induced bycommensals through NOD1 regulates intestinal homeostasis.Nature 456, 507–510
22 Lugering, A. et al. (2010) CCR6 identifies lymphoid tissue inducer cellswithin cryptopatches. Clin. Exp. Immunol. 160, 440–449
23 Saito, H. et al. (1998) Generation of intestinal T cells from progenitorsresiding in gut cryptopatches. Science 280, 275–278
24 Lambolez, F. et al. (2006) The thymus exports long-lived fullycommitted T cell precursors that can colonize primary lymphoidorgans. Nat. Immunol. 7, 76–82
25 Pabst, O. et al. (2005) Cryptopatches and isolated lymphoid follicles:dynamic lymphoid tissues dispensable for the generation ofintraepithelial lymphocytes. Eur. J. Immunol. 35, 98–107
26 Hamada, H. et al. (2002) Identification of multiple isolated lymphoidfollicles on the antimesenteric wall of the mouse small intestine. J.Immunol. 168, 57–64
27 Randall, T.D. et al. (2008) Development of secondary lymphoid organs.Annu. Rev. Immunol. 26, 627–650
28 Lorenz, R.G. and Newberry, R.D. (2004) Isolated lymphoid follicles canfunction as sites for induction of mucosal immune responses.Ann. N. Y.Acad. Sci. 1029, 44–57
29 Tsuji, M. et al. (2008) Requirement for lymphoid tissue-inducer cells inisolated follicle formation and T cell-independent immunoglobulin Ageneration in the gut. Immunity 29, 261–271
30 Wang, C. et al. (2006) Murine isolated lymphoid follicles containfollicular B lymphocytes with a mucosal phenotype. Am. J. Physiol.Gastrointest. Liver Physiol. 291, G595–G604
31 Pabst, O. et al. (2006) Adaptation of solitary intestinal lymphoid tissuein response to microbiota and chemokine receptor CCR7 signaling. J.Immunol. 177, 6824–6832
32 Lorenz, R.G. et al. (2003) Isolated lymphoid follicle formation isinducible and dependent upon lymphotoxin-sufficient Blymphocytes, lymphotoxin beta receptor, and TNF receptor Ifunction. J. Immunol. 170, 5475–5482
33 Fagarasan, S. et al. (2002) Critical roles of activation-induced cytidinedeaminase in the homeostasis of gut flora. Science 298, 1424–1427
34 Cornes, J.S. (1965) Number, size, and distribution of Peyer’s patches inthe human small intestine: part I The development of Peyer’s patches.Gut 6, 225–229
35 Owen, R.L. et al. (1991) Ultrastructural and cytoarchitectural featuresof lymphoreticular organs in the colon and rectum of adult BALB/cmice. Am. J. Anat. 190, 10–18
36 Heel, K.A. et al. (1997) Review: Peyer’s patches. J. Gastroenterol.Hepatol. 12, 122–136
37 Hooper, L.V. (2004) Bacterial contributions to mammalian gutdevelopment. Trends Microbiol. 12, 129–134
38 Pickard, J.M. and Chervonsky, A.V. (2010) Sampling of the intestinalmicrobiota by epithelial M cells. Curr. Gastroenterol. Rep. 12, 331–339
39 Sawa, S. et al. (2010) Lineage relationship analysis of RORgammat+innate lymphoid cells. Science 330, 665–669
40 Lochner, M. et al. (2011) Microbiota-induced tertiary lymphoid tissuesaggravate inflammatory disease in the absence of RORgamma t andLTi cells. J. Exp. Med. 208, 125–134
41 Vonarbourg, C. et al. (2010) Regulated expression of nuclear receptorRORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33, 736–751
42 O’Shea, J.J. and Paul, W.E. (2010) Mechanisms underlying lineagecommitment and plasticity of helper CD4+ T cells. Science 327, 1098–1102
43 Cua, D.J. and Tato, C.M. (2010) Innate IL-17-producing cells: thesentinels of the immune system. Nat. Rev. Immunol. 10, 479–489
44 Maloy, K.J. and Powrie, F. (2011) Intestinal homeostasis and itsbreakdown in inflammatory bowel disease. Nature 474, 298–306
45 Wolk, K. et al. (2004) IL-22 increases the innate immunity of tissues.Immunity 21, 241–254
46 Sonnenberg, G.F. et al. (2011) Border patrol: regulation of immunity,inflammation and tissue homeostasis at barrier surfaces by IL-22.Nat.Immunol. 12, 383–390
47 Zhou, L. et al. (2007) IL-6 programs T(H)-17 cell differentiation bypromoting sequential engagement of the IL-21 and IL-23 pathways.Nat. Immunol. 8, 967–974
48 Mangan, P.R. et al. (2006) Transforming growth factor-beta inducesdevelopment of the T(H)17 lineage. Nature 441, 231–234
49 Ahern, P.P. et al. (2010) Interleukin-23 drives intestinal inflammationthrough direct activity on T cells. Immunity 33, 279–288
50 Buonocore, S. et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371–1375
51 Sonnenberg, G.F. et al. (2011) CD4(+) lymphoid tissue-inducer cellspromote innate immunity in the gut. Immunity 34, 122–134
52 Satoh-Takayama, N. et al. (2009) The natural cytotoxicity receptorNKp46 is dispensable for IL-22-mediated innate intestinal immunedefense against Citrobacter rodentium. J. Immunol. 183, 6579–6587
53 Satoh-Takayama, N. et al. (2008) Microbial flora drives interleukin 22production in intestinal NKp46+ cells that provide innate mucosalimmune defense. Immunity 29, 958–970
295
Review Trends in Immunology June 2012, Vol. 33, No. 6
54 Crellin, N.K. et al. (2010) Human NKp44+IL-22+ cells and LTi-likecells constitute a stable RORC+ lineage distinct from conventionalnatural killer cells. J. Exp. Med. 207, 281–290
55 Cupedo, T. et al. (2009) Human fetal lymphoid tissue-inducer cells areinterleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10, 66–74
56 Cella, M. et al. (2010) Expansion of human NK-22 cells with IL-7, IL-2,and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad.Sci. U.S.A. 107, 10961–10966
57 Geremia, A. et al. (2011) IL-23-responsive innate lymphoid cells areincreased in inflammatory bowel disease. J. Exp. Med. 208, 1127–1133
58 Sawa, S. et al. (2011) RORgammat+ innate lymphoid cells regulateintestinal homeostasis by integrating negative signals from thesymbiotic microbiota. Nat. Immunol. 12, 320–326
59 Stockinger, B. et al. (2011) External influences on the immune systemvia activation of the aryl hydrocarbon receptor. Semin. Immunol. 23,99–105
60 Kiss, E.A. et al. (2011) Natural aryl hydrocarbon receptor ligandscontrol organogenesis of intestinal lymphoid follicles. Science 334,1561–1565
61 Neill, D.R. et al. (2010) Nuocytes represent a new innate effectorleukocyte that mediates type-2 immunity. Nature 464, 1367–1370
296
62 Moro, K. et al. (2010) Innate production of T(H)2 cytokines by adiposetissue-associated c-Kit(+)Sca-1(+) lymphoid cells.Nature 463, 540–544
63 Wong, S.H. et al. (2012) Transcription factor RORalpha is critical fornuocyte development. Nat. Immunol. 13, 229–236
64 Saenz, S.A. et al. (2010) IL25 elicits a multipotent progenitor cellpopulation that promotes T(H)2 cytokine responses. Nature 464,1362–1366
65 Monticelli, L.A. et al. (2011) Innate lymphoid cells promote lung-tissuehomeostasis after infection with influenza virus. Nat. Immunol. 12,1045–1054
66 Mjosberg, J.M. et al. (2011) Human IL-25- and IL-33-responsive type 2innate lymphoid cells are defined by expression of CRTH2 and CD161.Nat. Immunol. 12, 1055–1062
67 Lane, P.J. et al. (2009) Lymphoid tissue inducer cells: bridges betweenthe ancient innate and themodern adaptive immune systems.MucosalImmunol. 2, 472–477
68 Kim, M.Y. et al. (2006) Neonatal and adult CD4+ CD3– cells sharesimilar gene expression profile, and neonatal cells up-regulate OX40ligand in response to TL1A (TNFSF15). J. Immunol. 177, 3074–3081
69 Kim, M.Y. et al. (2003) CD4(+)CD3(–) accessory cells costimulateprimed CD4 T cells through OX40 and CD30 at sites where T cellscollaborate with B cells. Immunity 18, 643–654